Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-22
2010-12-07
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S373100
Reexamination Certificate
active
07846960
ABSTRACT:
Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
REFERENCES:
patent: 5990139 (1999-11-01), Yano et al.
patent: WO 03/015771 (2003-02-01), None
patent: WO 2004/048349 (2004-06-01), None
patent: WO 2005/065683 (2005-07-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta et al., abstract, Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Bell Michael Gregory
Doti Robert Anthony
Genin Michael James
Lander Peter Ambrose
Ma Tianwei
Eli Lilly and Company
Ginah Francis O.
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
FXR agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FXR agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FXR agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4228445